Literature DB >> 10099829

Dose-dependent effects of DNA-damaging agents on p53-mediated cell cycle arrest.

D Chang1, F Chen, F Zhang, B C McKay, M Ljungman.   

Abstract

We examined the dose-dependent effects of DNA-damaging agents on G1 arrest in isogenic human cell lines differing in their p53 status. As expected, 5 or 20 Gy of ionizing radiation induced a p53-dependent G1 arrest. In contrast, UV light or actinomycin D induced a modest G1 arrest that was p53-dependent only at lower doses. At higher doses, cells were arrested in G1 in a p53-independent manner coinciding with inhibition of RNA synthesis and abolished cyclin E expression. Interestingly, expression of cyclin E was enhanced after exposure to moderate doses of UV light and actinomycin D, and this enhancement was suppressed by wild-type p53. We propose that agents inducing transcription-blocking DNA lesions will at higher doses inhibit the progression of cells into S phase by a p53-independent mechanism involving the attenuation of E2F-mediated transcription of genes, such as cyclin E.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10099829

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  14 in total

1.  The tumor suppressor p53 can both stimulate and inhibit ultraviolet light-induced apoptosis.

Authors:  B C McKay; F Chen; C R Perumalswami; F Zhang; M Ljungman
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

2.  Role for p53 in the recovery of transcription and protection against apoptosis induced by ultraviolet light.

Authors:  B C McKay; M Ljungman
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

3.  Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest.

Authors:  Luciana E Giono; James J Manfredi
Journal:  Mol Cell Biol       Date:  2007-03-19       Impact factor: 4.272

4.  Differential role of transcription-coupled repair in UVB-induced G2 arrest and apoptosis in mouse epidermis.

Authors:  M van Oosten; H Rebel; E C Friedberg; H van Steeg; G T van der Horst; H J van Kranen; A Westerman; A A van Zeeland; L H Mullenders; F R de Gruijl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

5.  Nucleophosmin sets a threshold for p53 response to UV radiation.

Authors:  Dony A Maiguel; Leslie Jones; Devulapalli Chakravarty; Chonglin Yang; France Carrier
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

6.  A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53.

Authors:  Surojit Sur; Raymond Pagliarini; Fred Bunz; Carlo Rago; Luis A Diaz; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

7.  Cells from long-lived mutant mice exhibit enhanced repair of ultraviolet lesions.

Authors:  Adam B Salmon; Mats Ljungman; Richard A Miller
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-03       Impact factor: 6.053

8.  Psoralen-induced DNA interstrand cross-links block transcription and induce p53 in an ataxia-telangiectasia and rad3-related-dependent manner.

Authors:  Frederick A Derheimer; J Kevin Hicks; Michelle T Paulsen; Christine E Canman; Mats Ljungman
Journal:  Mol Pharmacol       Date:  2008-12-08       Impact factor: 4.436

9.  Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion.

Authors:  S H Khan; J Moritsugu; G M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT.

Authors:  Enke Baldini; Yannick Arlot-Bonnemains; Salvatore Sorrenti; Caterina Mian; Maria R Pelizzo; Enrico De Antoni; Silvio Palermo; Stefania Morrone; Susi Barollo; Angela Nesca; Costanzo G Moretti; Massimino D'Armiento; Salvatore Ulisse
Journal:  BMC Cancer       Date:  2011-09-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.